Days of bleeding · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
MBL (mL per cycle) · women with heavy menstrual bleeding
1 finding from 1 review
Number of days' bleeding · women with heavy menstrual bleeding
1 finding from 1 review
Quality of life · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of days' bleeding · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
MBL (mL per cycle) · women with heavy menstrual bleeding
1 finding from 1 review
Proportion of women with no subjective improvement in MBL · women with heavy menstrual bleeding
NSAIDs showed no clear difference in proportion of women with no subjective improvement in MBL compared with tranexamic acid (control) (low certainty).
1 finding from 1 review
Number of days' bleeding · women with heavy menstrual bleeding
1 finding from 1 review
Quality of life · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
MBL (mL per cycle) · women with heavy menstrual bleeding
1 finding from 1 review
Menstrual blood loss: mean loss · women with heavy menstrual bleeding
1 finding from 1 review
Quality of life · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects: headache · women with heavy menstrual bleeding
Progestogen therapy long cycle (3 to 4 weeks) showed no clear difference in adverse effect Headache compared with other medical therapy (low certainty).
1 finding from 1 review
Adverse effect Breakthrough bleeding/spotting · women with heavy menstrual bleeding
Progestogen therapy long cycle (3 to 4 weeks) may leads to lower adverse effect Breakthrough bleeding/spotting compared with other medical therapy (low certainty).
1 finding from 1 review
Satisfaction · women with heavy menstrual bleeding
It is very uncertain whether progestogen therapy (luteal phase only) changes satisfaction compared with other medical therapy (very low certainty).
1 finding from 1 review
Days of bleeding · women with heavy menstrual bleeding
1 finding from 1 review
Physical functioning component of health‐related quality of life, measured using various scales · women with heavy menstrual bleeding
1 finding from 1 review
Total adverse effects · women with heavy menstrual bleeding
It is very uncertain whether progestogen therapy (luteal phase only) changes total adverse effects compared with other medical therapy (very low certainty).
1 finding from 1 review
Menstrual blood loss PBAC score · women with heavy menstrual bleeding
2 findings from 1 review